Pfizer will dominate $28 billion COVID-pill market in 2022
MELBOURNE: Pfizer is set to dominate a $US20 billion ($27.9 billion) market for COVID pills
MELBOURNE: Pfizer is set to dominate a $US20 billion ($27.9 billion) market for COVID pills
FEATURED
New apartments are helping transform the treatment experience
Plan unveiled to replace former care home with 24 modern retirement flats
Modernist architecture now set to meet affordable housing for seniors
Land carve-ups help build better housing future for remote communities
Best retirement housing design for Global Awards shortlisted
Boomers high-rise set to come with a health hub
INNOVATION
